Servicio de Cardiología, Hospital Universitario Virgen de la Victoria, Málaga, España.
Rev Esp Cardiol. 2011 Feb;64(2):155-8. doi: 10.1016/j.recesp.2010.03.001. Epub 2011 Jan 3.
Recently, percutaneous aortic valve replacement has emerged as a therapeutic option for patients with severe symptomatic aortic stenosis and a high surgical risk. We report our initial experience in four patients with percutaneous implantation of a CoreValve aortic prosthesis to treat aortic bioprosthesis dysfunction involving aortic stenosis or regurgitation. In-hospital and medium-term outcomes were analyzed. The procedure was performed under local anesthesia and guided by angiography. The prosthesis was implanted successfully in all patients, although a second prosthesis was required in one case because the first was positioned too high. There were no major complications. After a mean follow-up of 7 months (SD, 4.7), all patients remained asymptomatic.
最近，经皮主动脉瓣置换术已成为严重症状性主动脉瓣狭窄且手术风险高的患者的一种治疗选择。我们报告了在 4 例患者中经皮植入 CoreValve 主动脉假体治疗主动脉生物瓣功能障碍（包括主动脉瓣狭窄或反流）的初步经验。分析了住院期间和中期结果。该手术在局部麻醉下进行，并通过血管造影引导。尽管在 1 例患者中需要植入第二个假体，因为第一个假体位置过高，但所有患者的假体均成功植入，无重大并发症。平均随访 7 个月（SD，4.7）后，所有患者均无症状。
